NOBUYUKI CHIKUIE (Hiroshima University Hospital(Medical))

Basic Information

2023, Undergraduate Education, Year, Clinical diagnosis and treatment II
2023, Undergraduate Education, Intensive, Practice of Medicine I
2023, Liberal Arts Education Program1, 1Term, Introductory Seminar for First-Year Students
2023, Undergraduate Education, 2Term, Otorhinology
2023, Graduate Education (Doctoral Program) , First Semester, Advanced Seminar on Otorhinolaryngology,Head and Neck Surgery
2023, Graduate Education (Doctoral Program) , Second Semester, Advanced Seminar on Otorhinolaryngology,Head and Neck Surgery
2023, Graduate Education (Doctoral Program) , First Semester, Advanced Research on Otorhinolaryngology,Head and Neck Surgery
2023, Graduate Education (Doctoral Program) , Second Semester, Advanced Research on Otorhinolaryngology,Head and Neck Surgery

Efficacy of anti-PD-1 therapy in a patient with brain metastasis of parotid carcinoma: A case report, Auris Nasus Larynx, 46(5), 813-817, 2019
Baseline neutrophil-to-lymphocyte ratio (NLR) is associated with clinical outcome in recurrent or metastatic head and neck cancer patients treated with nivolumab, Acta oto-laryngologica, 140(2), 181-187, 2020
Ganglioneuroma in the Neck Region: A Case Report, Hiroshima Journal of Medical Sciences, 68(2), 2019

Utility of plasma curcylating tumor DNA profiles in head and neck squamous cell carcinoma, Nobuyuki Chikuie, Tsutomu Ueda, Takao Hamamoto, Takayuki Taruya, Takashi Kono, Kohei Yumii, Sachio Takeno, IFOS DUBAI ENT WORLD CONGRESS 2023, 2023/01/18, Without Invitation, English